# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-24-000044
Filing Date
2024-08-06
Accepted
2024-08-06 16:07:29
Documents
83
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | halo-20240630.htm iXBRL | 10-Q | 1407340
2 | EX-10.1 | ex101formofrestrictedunita.htm | EX-10.1 | 70798
3 | EX-31.1 | ex31110qq22024.htm | EX-31.1 | 12955
4 | EX-31.2 | ex31210qq22024.htm | EX-31.2 | 12895
5 | EX-32 | ex3210qq22024.htm | EX-32 | 13879
11 | GRAPHIC | halo-20240630_g1.jpg | GRAPHIC | 15840
12 | GRAPHIC | halo-20240630_g2.jpg | GRAPHIC | 147351
13 | GRAPHIC | halo-20240630_g3.jpg | GRAPHIC | 77244
| Complete submission text file | 0001159036-24-000044.txt |  | 8825133

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | halo-20240630.xsd | EX-101.SCH | 48619
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | halo-20240630_cal.xml | EX-101.CAL | 81561
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | halo-20240630_def.xml | EX-101.DEF | 263746
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | halo-20240630_lab.xml | EX-101.LAB | 676300
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | halo-20240630_pre.xml | EX-101.PRE | 471247
86 | EXTRACTED XBRL INSTANCE DOCUMENT | halo-20240630_htm.xml | XML | 1295505

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 241179196
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)